Magnesium sulfate and Infection in an immunocompromised host - a phase IV clinical study of FDA data

Summary:

Infection in an immunocompromised host is found among people who take Magnesium sulfate, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Magnesium sulfate and have Infection in an immunocompromised host. It is created by eHealthMe based on reports of 14,870 people who have side effects when taking Magnesium sulfate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 30, 2022

14,870 people reported to have side effects when taking Magnesium sulfate.
Among them, 7 people (0.05%) have Infection in an immunocompromised host.


What is Magnesium sulfate?

Magnesium sulfate has active ingredients of magnesium sulfate. It is often used in migraine. eHealthMe is studying from 15,316 Magnesium sulfate users for its effectiveness, alternative drugs and more.

What is Infection in an immunocompromised host?

Infection in an immunocompromised host is found to be associated with 493 drugs and 246 conditions by eHealthMe.

Number of Magnesium sulfate and Infection in an immunocompromised host reports submitted per year:

Could Magnesium sulfate cause Infection in an immunocompromised host?

Gender of people who have Infection in an immunocompromised host when taking Magnesium sulfate *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Infection in an immunocompromised host when taking Magnesium sulfate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 50 %
  • 60+: 50 %

Common drugs people take besides Magnesium sulfate *:

  1. Cymbalta: 4 people, 57.14%
  2. Roxicodone: 4 people, 57.14%
  3. Lidoderm: 4 people, 57.14%
  4. Lyrica: 4 people, 57.14%
  5. Inositol: 4 people, 57.14%
  6. Xyrem: 4 people, 57.14%
  7. Imodium: 4 people, 57.14%
  8. Pepcid Ac: 4 people, 57.14%
  9. Elmiron: 4 people, 57.14%
  10. Lamictal: 4 people, 57.14%

Common side effects people have besides Infection in an immunocompromised host *:

  1. Drug Dependence: 4 people, 57.14%
  2. Nausea (feeling of having an urge to vomit): 4 people, 57.14%
  3. Pre-Existing Condition Improved: 4 people, 57.14%
  4. Nausea And Vomiting: 4 people, 57.14%
  5. Hepatomegaly (abnormal enlargement of the liver): 4 people, 57.14%
  6. Therapeutic Response Unexpected: 3 people, 42.86%
  7. Drug Ineffective: 3 people, 42.86%
  8. Crying: 3 people, 42.86%
  9. White Blood Cell Count Decreased: 1 person, 14.29%
  10. Haemoglobin Decreased: 1 person, 14.29%

Common conditions people have *:

  1. Insomnia (sleeplessness): 4 people, 57.14%
  2. Respiratory Distress (difficulty in breathing): 1 person, 14.29%
  3. Multiple Myeloma (cancer of the plasma cells): 1 person, 14.29%
  4. Asthma: 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium sulfate and have Infection in an immunocompromised host?

Check whether Infection in an immunocompromised host is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Infection in an immunocompromised host and when was it recovered:

Expand to all the drugs that have ingredients of magnesium sulfate:

Alternative drugs to, pros and cons of Magnesium sulfate:

Common Magnesium sulfate side effects:

Browse all side effects of Magnesium sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Infection in an immunocompromised host treatments and more:

COVID vaccines that are related to Infection in an immunocompromised host:

Common drugs associated with Infection in an immunocompromised host:

All the drugs that are associated with Infection in an immunocompromised host:

All the conditions that are associated with Infection in an immunocompromised host:

How the study uses the data?

The study uses data from the FDA. It is based on magnesium sulfate (the active ingredients of Magnesium sulfate) and Magnesium sulfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: